Prevention of Drug-Induced Anemia or Thrombocytopenia

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. (opens new window)

Brunner B, Hoeck M, Schermer E, Streif W, Kiechl-Kohlendorfer U.

Source‎: J Pediatr 2013;163(1):23-8.

Indexed‎: PubMed 23351600

DOI‎: 10.1016/j.jpeds.2012.12.035

https://www.ncbi.nlm.nih.gov/pubmed/23351600 (opens new window)

Natalizumab use during the third trimester of pregnancy. (opens new window)

Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K.

Source‎: JAMA Neurol 2014;71(7):891-5.

Indexed‎: PubMed 24821217

DOI‎: 10.1001/jamaneurol.2014.209

https://www.ncbi.nlm.nih.gov/pubmed/24821217 (opens new window)

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. (opens new window)

Mehler K, Oberthuer A, Weisshaar G, Valter M, Vierzig A, Eifinger F.

Source‎: Klin Padiatr 2013;225(5):263-5.

Indexed‎: PubMed 23519748

DOI‎: 10.1055/s-0033-1333756

https://www.ncbi.nlm.nih.gov/pubmed/23519748 (opens new window)

Drug-induced thrombocytopenia in children. (opens new window)

Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK, George JN.

Source‎: Pediatr Blood Cancer 2013;60(12):1975-81.

Indexed‎: PubMed 24038783

DOI‎: 10.1002/pbc.24682

https://www.ncbi.nlm.nih.gov/pubmed/24038783 (opens new window)

NEONATAL MEDICINE

Prevention of Drug-Induced Anemia or Thrombocytopenia

English

Prevention of Drug-Induced Anemia or Thrombocytopenia

https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Prevention of Drug-Induced Anemia or Thrombocytopenia

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. (opens new window)

Natalizumab use during the third trimester of pregnancy. (opens new window)

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. (opens new window)

Drug-induced thrombocytopenia in children. (opens new window)

Hospital Liaison Committee (HLC)

Medical Information Packets

Videos

Prevention of Drug-Induced Anemia or Thrombocytopenia

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. (opens new window)

Natalizumab use during the third trimester of pregnancy. (opens new window)

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. (opens new window)

Drug-induced thrombocytopenia in children. (opens new window)

Hospital Liaison Committee (HLC)

Medical Information Packets

Videos

Select Your Language

Share